Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Aim</h3><p>Trimethoprim‐sulfamethoxazole (TMP‐SMX) is an important cause of idiosyncratic drug induced liver injury (DILI), but its genetic risk factors are not well understood. We investigated the relationship between variants in the HLA Class I and II genes and well characterized cases of TMP‐SMX DILI.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>European American and African American persons with TMP‐SMX DILI were compared to respective population controls. HLA sequencing was performed by Illumina MiSeq for cases. HLA genotype imputation with attribute bagging (HIBAG) program was used to impute HLA alleles for controls. Allele frequency difference between cases and controls was tested by Fisher exact tests per ethnic group. For European Americans, multivariable logistic regression with Firth penalization was used to test HLA allelic effect after adjusting for age and the top two principal components. Molecular docking was performed to assess the HLA binding with TMP and SMX.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The European American subset had 51 cases and 12,156 controls, while the African American subset had 10 cases and 5,439 controls. Four HLA alleles were significantly associated in the European American subset, with <i>HLA‐B*14:01</i> ranking at the top (OR: 9.20, 95% CI: 3.16‐22.35, p=0.0003) after covariate adjustment. All <i>HLA‐B*14:01</i> carriers with TMP‐SMX DILI possessed <i>HLA‐C*08:02,</i> another significant allele (p=0.0026). This pattern was supported by <i>HLA‐B*14:01‐HLA‐C*08:02</i> haplotype association (p=1.33x10<sup>‐5</sup>). For the African Americans, <i>HLA‐B*35:01</i> had 2.8‐fold higher frequency in cases than in controls, with five of 10 patients carrying this allele. Molecular docking showed Cys<sup>67</sup> in <i>HLA‐B*14:01</i> and Phe<sup>67</sup> in <i>HLA‐B*35:01</i> to be the predictive binding sites to SMX metabolites. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p><i>HLA‐B*14:01</i> is associated with TMP‐SMX DILI in European Americans, and <i>HLA‐B*35:01</i> may be a potential genetic risk factor for African Americans. </p></section>

Advance on the Association of Drug-induced Liver Injury and HLA Gene Polymorphism

Association Between Human Leukocyte Antigen Gene Polymorphism and Drug-Induced Liver Injury

Research Advances in the Association of Drug-Induced Liver Injury with Polymorphisms in Human Leukocyte Antigen.

Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?

Progress in Study on the Association Between HLA Genetic Variation and Adverse Drug Reactions.

The Association Between HLA-DQB1 Polymorphism and Antituberculosis Drug-Induced Liver Injury: a Case-Control Study.

HLA-A*33:01 is strongly associated with drug-induced liver injury (DILI) due to terbinafine and several other unrelated compounds

HLA Association with Drug-Induced Adverse Reactions

[Importance of HLA in Determining Individual Differences in the Onset of Adverse Drug Reactions]

[Pharmacogenetic research in the association between human leukocyte antigen and adverse drug reactions].

Correlation of Polymorphism in the Interleukin-1 Receptor Antagonist Gene Intron 2 with Alcoholic Liver Disease.

Human Leukocyte Antigen B14:01 and B35:01 Are Associated With Trimethoprim‐Sulfamethoxazole Induced Liver Injury

[The Associations Between Idiosyncratic Adverse Drug Reactions and HLA Alleles and Their Underlying Mechanism].

Drug‐induced liver injury (DILI) ascribed to non‐steroidal anti‐inflammatory drugs (NSAIDs) in the USA—Update with genetic correlations

Association Study of Ugt1a9 Promoter Polymorphisms with Dili Based on Systematically Regional Variation Screen in Chinese Population

Study on polymorphisms of genes with susceptibility to drug induced liver injury in a cohort receiving anti-tuberculosis treatment

Prospective Study Of Aldh1a1 Gene Polymorphisms Associated With Antituberculosis Drug-Induced Liver Injury In Western Chinese Han Population

Polymorphisms in CTLA4 Influence Incidence of Drug-Induced Liver Injury after Renal Transplantation in Chinese Recipients.

Pharmacogenetic Study Of Drug-Metabolising Enzyme Polymorphisms On The Risk Of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis

A Meta-Analysis of HLA-DR Polymorphism and Genetic Susceptibility to Idiopathic Dilated Cardiomyopathy

Identification of reduced ERAP2 expression and a novel HLA allele as components of a risk score for susceptibility to liver injury due to amoxicillin-clavulanate